The Impact of 52-Week Single Inhaler Device Triple Therapy versus Dual Therapy on the Mortality of COPD Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

There are more single inhaler device triple therapy available for COPD patients now. However, the effect of long-term triple therapy fixed dose combination (FDC) on mortality remains unclear. This study aimed to evaluate the impact of one-year single inhaler device triple therapy, including long-act...

Descripción completa

Detalles Bibliográficos
Autores principales: Lai, Chih-Cheng, Chen, Chao-Hsien, Chen, Kuang-Hung, Wang, Cheng-Yi, Huang, Tsan-Ming, Wang, Ya-Hui, Wang, Hao-Chien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8877713/
https://www.ncbi.nlm.nih.gov/pubmed/35207460
http://dx.doi.org/10.3390/life12020173

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8877713/
https://www.ncbi.nlm.nih.gov/pubmed/35207460
http://dx.doi.org/10.3390/life12020173

Ejemplares similares